Literature DB >> 8549023

Pharmacokinetic-pharmacodynamic modelling as applied to bronchial asthma.

R P Koopmans1, R E Jonkers, M C Braat, C J van Boxtel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549023     DOI： 10.2165/00003088-199529040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  39 in total

1.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

2.  Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans.

Authors:  B Oosterhuis; I J ten Berge; P T Schellekens; C J van Boxtel
Journal:  J Pharmacol Exp Ther       Date:  1987-11       Impact factor: 4.030

3.  Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals.

Authors:  E Bloemena; R P Koopmans; S Weinreich; C J van Boxtel; P T Schellekens
Journal:  Clin Immunol Immunopathol       Date:  1990-12

4.  Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.

Authors:  B Billing; R Dahlqvist; M Garle; Y Hörnblad; E Ripe
Journal:  Eur J Respir Dis       Date:  1982-09

Review 5.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

6.  Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model.

Authors:  R P Koopmans; M C Braat; B Oosterhuis; C J van Boxtel
Journal:  J Pharmacol Exp Ther       Date:  1992-08       Impact factor: 4.030

7.  Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.

Authors:  A N Kong; E A Ludwig; R L Slaughter; P M DiStefano; J DeMasi; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1989-12       Impact factor: 6.875

8.  Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial.

Authors:  N Holford; P Black; R Couch; J Kennedy; R Briant
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

9.  Pharmacokinetic-pharmacodynamic modeling of terbutaline bronchodilation in asthma.

Authors:  B Oosterhuis; M C Braat; C M Roos; J Wemer; C J Van Boxtel
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

Review 10.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.